Related Experiment Video
Updated: Jun 2, 2026
14:57
Preparation of Acute Hippocampal Slices from Rats and Transgenic Mice for the Study of Synaptic Alterations during Aging and Amyloid Pathology
Published on: March 23, 2011
Chromosomal aneuploidy in the aging brain.
Francesca Faggioli1, Jan Vijg, Cristina Montagna
1Department of Genetics, Albert Einstein College of Medicine of Yeshiva University, Bronx, NY 10461, USA.
Mechanisms of Ageing and Development
|May 10, 2011
Summary
Genomic instability, specifically aneuploidy (abnormal chromosome numbers), may contribute to brain aging and neurodegenerative diseases. Understanding this link is crucial for addressing age-related cognitive decline.
Area of Science:
- Neuroscience
- Genetics
- Cell Biology
Background:
- Genome integrity is vital for longevity and preventing age-related decline.
- Neuronal function declines with age, increasing risks for neurodegenerative diseases.
- The underlying biological mechanisms of brain aging are not fully understood.
Purpose of the Study:
- To review the role of chromosomal aneuploidy in the aging brain.
- To explore the causes and consequences of aneuploidy in aging neurons.
- To examine the potential link between aneuploidy and age-related functional decline and neuropathies.
Main Methods:
- Literature review of studies on genome instability, aneuploidy, and brain aging.
- Analysis of research linking chromosomal abnormalities to cellular homeostasis.
- Synthesis of evidence connecting aneuploidy to neurodegeneration and cognitive impairment.
Main Results:
- Aneuploidy, a deviation from normal chromosome content, is a form of genomic instability.
- Aneuploidy has been implicated in the neurodegenerative processes associated with aging.
- This review synthesizes current understanding of aneuploidy's impact on the aging brain.
Conclusions:
- Chromosomal aneuploidy is a significant factor in the aging brain.
- Aneuploidy can disrupt cellular homeostasis, contributing to neuronal dysfunction.
- Further research into aneuploidy may reveal new therapeutic targets for age-related cognitive decline and neuropathies.
Related Concept Videos
01:21Nondisjunction
Nondisjunction is the failure of homologous chromosomes or sister chromatids to separate correctly and move to the opposite poles of the cells. This produces daughter cells with abnormal chromosome numbers. Nondisjunction is common during anaphase I or anaphase II of meiosis. Mutations in synaptonemal complex proteins that attach homologous chromosomes increase the chances of nondisjunction in anaphase I of meiosis I. In contrast, mutations in topoisomerases and condensins that hold sister...
01:29Nondisjunction
During meiosis, chromosomes occasionally separate improperly. This occurs due to failure of homologous chromosome separation during meiosis I or failed sister chromatid separation during meiosis II. In some species, notably plants, nondisjunction can result in an organism with an entire additional set of chromosomes, which is called polyploidy. In humans, nondisjunction can occur during male or female gametogenesis and the resulting gametes possess one too many or one too few chromosomes.
01:26Aging
Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
01:26Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...